Valuation : MedPacto, Inc.

Market Cap 94.26B 70.32M 60.59M 57.37M 52M 97.55M 6.72B 98.04M 681M 262M 3.42B 264M 258M 10.8B P/E 2024
-7.42x
P/E 2025 -17.9x
Enterprise Value 55.28B 41.24M 35.53M 33.65M 30.5M 57.21M 3.94B 57.5M 400M 154M 2B 155M 151M 6.33B EV / Sales 2024
-
EV / Sales 2025 48,733,025x
Free-Float
74%
Yield 2024 *
-
Yield 2025 -
1 day-2.31%
1 week-4.84%
Current month-1.26%
1 month-7.09%
3 months-19.35%
6 months-46.39%
Current year-58.83%
1 week 2,600
Extreme 2600
2,990
1 month 2,390
Extreme 2390
2,990
Current year 2,235
Extreme 2235
7,980
1 year 2,235
Extreme 2235
8,650
3 years 2,235
Extreme 2235
17,240
5 years 2,235
Extreme 2235
69,600
10 years 2,235
Extreme 2235
134,200
Manager TitleAgeSince
Chief Executive Officer 72 2013-06-18
President 66 2024-03-27
Comptroller/Controller/Auditor 70 2022-03-27
Director TitleAgeSince
Director/Board Member 72 2013-06-18
Director/Board Member 66 2024-03-27
Director/Board Member 64 2024-03-27
Date Insider Type Main position Quantity % Market Cap. Importance
3/4/25 Buy 10,000 0.0292%
3/4/25 Buy 10,500 0.0306%
3/4/25 Buy

Chairperson

15,000 0.0438%
Change 5-day change 1-year change 3-year change Capi.($)
-2.31%-4.84%-48.11%-80.62% 70.32M
-2.11%-1.68%+44.52%+95.15% 66.93B
-0.23%-4.45%+30.39%+73.64% 61.97B
+1.67%+2.47%-11.23%+388.34% 28.27B
-1.05%-4.43%+30.56%+10.07% 24.59B
+0.34%-6.78%-7.27%-17.99% 24.3B
+0.43%-3.37%+14.85%-19.29% 19.41B
-3.03%-2.29%+185.12%+334.07% 16.77B
-1.94%-4.94%-5.29%+495.65% 14.18B
-2.28%-4.90%+43.64%+155.21% 13.91B
Average -1.05%-3.48%+27.72%+143.42% 27.04B
Weighted average by Cap. -0.84%-3.06%+33.44%+133.61%

Financials

2024 2025
Net sales - 3.9K 2.91 2.51 2.37 2.15 4.03 277.85 4.06 28.18 10.84 141.36 10.92 10.68 446.67
Net income -20.14B -15.03M -12.95M -12.26M -11.11M -20.84M -1.44B -20.95M -146M -55.98M -730M -56.43M -55.19M -2.31B -12.81B -9.56M -8.23M -7.8M -7.07M -13.26M -913M -13.33M -92.6M -35.61M -465M -35.89M -35.11M -1.47B
Net Debt -53.54B -39.94M -34.41M -32.58M -29.53M -55.41M -3.82B -55.69M -387M -149M -1.94B -150M -147M -6.13B -38.97B -29.07M -25.05M -23.72M -21.5M -40.33M -2.78B -40.54M -282M -108M -1.41B -109M -107M -4.47B
Logo MedPacto, Inc.
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.
Employees
56
Date Price Change Volume
26-09-11 ₩2,750.00 -2.31% 145,515
26-09-10 ₩2,815.00 +1.62% 69,438
26-09-09 ₩2,770.00 0.00% 66,917
26-09-08 ₩2,770.00 -2.98% 55,173
26-09-07 ₩2,855.00 -1.21% 53,259
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A235980 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!